Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report
Infectious Diseases: News, Opinions, Training
; - (1):123-127, 2023.
Article
in Russian
| EMBASE | ID: covidwho-2321948
ABSTRACT
The multisystem inflammatory syndrome associated with COVID-19 coronavirus infection was first described in April-May 2020, mainly among children who had an acute infectious disease. Soon there were reports of the development of MIS in adults (MIS-A). More than 200 cases of MVS in adults have been described and systematized in the world, while in Russia there is no separate registration of MVS, a single description of MVS is given in the literature. Material and methods. We presented Case report of MIS-A in a 21-year-old woman, accompanied by persistent fever, multiple organ failure syndrome, is presented. The stages of diagnosis and treatment of MIS-A. Result and discussion. A positive effect was achieved during therapy with corticosteroids and intravenous immunoglobulin. MIS-A is a rare life-threatening complication of a COVID-19 that requires emergency therapy with the inclusion of corticosteroids and intravenous immunoglobulin in an adequate dose. The given example will be interesting for general practitioners, infectious disease specialists and therapists.Copyright © 2023 The authors.
adults; covid-19; intensive care; mis-a; adult; article; case report; clinical article; coronavirus disease 2019; disease association; emergency treatment; female; fever; general practitioner; human; infectious disease specialist; multiple organ failure; systemic inflammatory response syndrome/dt [Drug Therapy]; young adult; corticosteroid/dt [Drug Therapy]; immunoglobulin/dt [Drug Therapy]; immunoglobulin/iv [Intravenous Drug Administration]
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Language:
Russian
Journal:
Infectious Diseases: News, Opinions, Training
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS